Penumbra, Inc. - stock earnings
PEN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 54.2 million USD | 284.7 million USD |
| 2023Q3 | 9.2 million USD | 270.9 million USD |
| 2023Q2 | 19.0 million USD | 261.5 million USD |
| 2023Q1 | 8.6 million USD | 241.4 million USD |
| 2022Q4 | 3.9 million USD | 221.2 million USD |
| 2022Q3 | -2.3 million USD | 213.7 million USD |
| 2022Q2 | -3.7 million USD | 208.3 million USD |
| 2022Q1 | 79000 USD | 203.9 million USD |
| 2021Q4 | -24.6 million USD | 204.0 million USD |
| 2021Q3 | 8.9 million USD | 190.1 million USD |
| 2021Q2 | 9.2 million USD | 184.3 million USD |
| 2021Q1 | 11.8 million USD | 169.2 million USD |
| 2020Q4 | 3.6 million USD | 166.9 million USD |
| 2020Q3 | -8.8 million USD | 151.1 million USD |
| 2020Q2 | -12.0 million USD | 105.1 million USD |
| 2020Q1 | 1.4 million USD | 137.3 million USD |
| 2019Q4 | 9.7 million USD | 145.3 million USD |
| 2019Q3 | 11.5 million USD | 139.5 million USD |
| 2019Q2 | 16.6 million USD | 134.2 million USD |
| 2019Q1 | 10.7 million USD | 128.4 million USD |
| 2018Q4 | 6.7 million USD | 120.8 million USD |
| 2018Q3 | -18.9 million USD | 111.8 million USD |
| 2018Q2 | 13.4 million USD | 109.6 million USD |
| 2018Q1 | 5.5 million USD | 102.7 million USD |
| 2017Q4 | 9.1 million USD | 96.1 million USD |
| 2017Q3 | 238000 USD | 83.9 million USD |
| 2017Q2 | -1.6 million USD | 80.6 million USD |
| 2017Q1 | -3.1 million USD | 73.2 million USD |
| 2016Q4 | -2.4 million USD | 73.1 million USD |
| 2016Q3 | -1.1 million USD | 67.2 million USD |
| 2016Q2 | 185000 USD | 65.1 million USD |
| 2016Q1 | 780000 USD | 57.9 million USD |
| 2015Q4 | 1.6 million USD | 54.4 million USD |
| 2015Q3 | 901000 USD | 50.4 million USD |
| 2015Q2 | -2.7 million USD | 42.3 million USD |
| 2015Q1 | 2.5 million USD | 39.0 million USD |
| 2014Q4 | 416000 USD | 35.4 million USD |
| 2014Q3 | 172000 USD | 32.5 million USD |
| 2014Q2 | 391000 USD | 31.5 million USD |
| 2014Q1 | 1.3 million USD | 26.2 million USD |
| 2013Q4 | 4.1 million USD | 88.8 million USD |
PEN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 91.0 million USD | 1.1 billion USD |
| 2022 | -2.0 million USD | 847.1 million USD |
| 2021 | 2.6 million USD | 747.6 million USD |
| 2020 | -19.3 million USD | 560.4 million USD |
| 2019 | 48.5 million USD | 547.4 million USD |
| 2018 | 6.6 million USD | 444.9 million USD |
| 2017 | 4.7 million USD | 333.8 million USD |
| 2016 | 14.8 million USD | 263.3 million USD |
| 2015 | 2.4 million USD | 186.1 million USD |
| 2014 | 2.2 million USD | 125.5 million USD |
| 2013 | 4.1 million USD | 88.8 million USD |
| 2012 | 2.0 million USD | 73.1 million USD |
PEN
Price: $206.06
52 week price:
Earnings Per Share: 2.31 USD
P/E Ratio: 257.58
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Volume: 268800
Ebitda: 1.8 millionMarket Capitalization: 8.7 billion